Page 7
Bayer’s finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetes · Finerenone significantly reduced the combined…
We are pleased to inform you that Clonmel Healthcare has been appointed the distributor for the brand ThermaCare® by Angelini’s ThermaCare® partner in Ireland Carysfort Healthcare. Clonmel Healthcare…
NILEMDO® (bempedoic acid), a new, first-in-class, oral treatment and NUSTENDI® (bempedoic acid / ezetimibe) receive approval from the European Commission ESC/EAS Guidelines recommend to intensively lower low-density lipoprotein…
View the full article – click on the link below Emerging evidence on use of remdesivir in COVID-19
Grünenthal Pharma Ltd are pleased to announce the completion of the transfer of the Marketing Authorization for Nexium (esomeprazole magnesium trihydrate) to Grünenthal Pharma Ltd on March 20th…
Dublin, Republic of Ireland, 2 December 2019 – Boehringer Ingelheim announced the launch of the Respimat® reusable inhaler in Ireland, which could lead to over 112,500 fewer inhalers…
Accord Healthcare is delighted to announce the launch of Prasugrel Accord 10 mg which is available in a pack size of 28 tablets. This medicine, co-administered with acetylsalicylic…
Accord Healthcare is delighted to announce the launch of Darunavir 800 mg x 30 Film-Coated Tablets. This medicine co-administered with low dose ritonavir is indicated in combination with…
Accord has once again teamed up with Pharmabuddy to provide pharmacists with further information on Biosimilar medicines. In 2017 The National Cancer Control Programme (NCCP) stated that biosimilars…
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, has announced that the European Commission has granted Marketing…
You’re all caught up.
